Abstract Study question Does desogestrel an option for LH suppression during controlled ovarian stimulation oocyte vitrification? Summary answer This new did not affect FORT and, consequently, the number of collected oocytes vitrification. What is known already Traditionally, achieved by using a gonadotropin-releasing hormone (GnRH) analogue. However, improved cryopreservation techniques and fr...

Public Cit izen , represent i ng more than 100 ,000 con sumers nationwide , hereby pet itions the Food and Dr ug Adm i nistra tion (FDA) pursuant to the Federal Food , Drug and Cosmetic Act 2 1 U . S .C . Section 355(e)(3), and 21 C.F .R . 10 .30 , to immed iately ban the th ird generation oral contracept ives contain i~cn .dQmaParrPl d~~tothe approximately doubled risk of venous thrombosi s ( ...

A heterologous ELISA for measurement of osteocalcin (bone Gla-protein) is described, involving biotinylated bovine osteocalcin and polyclonal antibodies. The log-linear range was 2.3-37.5 micrograms/L. Between-run (total) and within-run CVs (n = 10) were 5.7-6.4 and 5.9-6.1%, respectively; analytical recoveries ranged from 92% to 108%. Comparison of our method (x) with an RIA (y) yielded y = 1....

The objectives of this study were to evaluate the endometrial histology and cervical cytology of users of two contraceptive implants releasing etonogestrel/3-keto-desogestrel (Implanon) and levonorgestrel (Norplant) in West Midlands (UK) users. A 2-year prospective randomized design was used to study 60 implant users. Endometrial histology and cervical cytology were compared before insertion an...